Published in Oncol Lett on February 28, 2014
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene (2015) 1.07
The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis (2015) 0.91
PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway. Oncotarget (2016) 0.84
CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo. Int J Clin Exp Pathol (2014) 0.84
Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis. Sci Rep (2016) 0.75
Extracellular HSP70/HSP70-PCs regulate hepatocarcinoma cell migration and invasion via RhoA. Oncol Lett (2016) 0.75
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
Cancer statistics, 2002. CA Cancer J Clin (2002) 10.79
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA (1998) 5.09
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med (2003) 2.91
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res (2002) 2.71
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol (2006) 2.36
Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res (1999) 2.17
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res (1995) 2.05
Stromal factors involved in prostate carcinoma metastasis to bone. Cancer (2003) 1.63
Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res (2001) 1.61
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol (2006) 1.46
Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res (2006) 1.45
Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res (2001) 1.45
Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res (2005) 1.39
Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother (2006) 1.31
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. Br J Cancer (2012) 1.25
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res (1999) 1.18
Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta (2002) 1.17
Mitogenic action of LPA in prostate. Biochim Biophys Acta (2002) 1.13
Current progress in non-Edg family LPA receptor research. Biochim Biophys Acta (2012) 1.07
Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat (2009) 1.02
Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8. Gynecol Oncol (2004) 1.02
Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma. Chin J Cancer (2011) 1.01
Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett (2003) 0.96
Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. J Natl Cancer Inst (2003) 0.95
Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells. Clin Cancer Res (1996) 0.94
The G-protein inhibitor, pertussis toxin, inhibits the secretion of brain-derived neurotrophic factor. Neuroscience (2000) 0.82